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ADC valueAbstract Objective: To evaluate diagnostic performance of diffusion weighted imaging (DWI) in
evaluating ovarian masses with suspicious features on magnetic resonance imaging (MRI).
Patients and methods: Pelvic MRI and DWI assessed 235 complex and solid ovarian masses of
suspicious MRI features. On DWI, scanning acquired by b values: 0, 500, 1000 and 1500.
Analysis considered signal intensity (SI) at b1000 and the mean ADC values for the solid
components of the masses.
Results: Included masses proved benign in 75(32%), borderline (low potential malignancy) in
55(23.4%) and malignant in 105(44.6%). Restricted diffusion was observed in all of the invasive
malignancy (57.1%, n= 105/184). Benign and borderline tumors with high DWI SI presented
15.2% and 27.7% respectively (P < 0.05). The mean ADC value was 1.2 + 0.34 · 103 mm2/s,
1.1 + 0.06 · 103 mm2/s, and 0.83 + 0.15 · 103 mm2/s for benign, borderline and malignant
masses respectively. The ADC values of malignant masses and benign masses with ﬁbrous
components showed no signiﬁcant difference (P= 0.333). Signiﬁcant difference was detected in
those with fatty tissue (P= 0.002).
Conclusion: DWI supported by conventional MRI data can conﬁrm or exclude malignancy in
suspicious ovarian masses. The combined analysis of quantitative and qualitative criteria and
knowledge of the sequence pitfalls are required.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ovarian masses present a special diagnostic challenge when
imaging ﬁndings cannot be categorized into benign or
malignant pathology (1).
Excessive surgical procedures such as bilateral oophorec-
tomy with or without hysterectomy have sometimes been
Table 1 MRI sequences used in the study.
Sequence TR
(ms)
TE
(ms)
FOV
(mm)
Matrix Slice
thickness
(mm)
T2 sagittal 3000 90 290 · 290 208 · 205 4
T2 axial 3700 100 288 · 350 292 · 180 5
T1 axial 500 10 260 · 216 263 · 171 5
T1 SPAIR axial 530 8 240 · 240 240 · 190 5
T2 coronal 5000 90 300 · 300 272 · 200 4.5
DWI (b 0, 500,
1000 &1500)
5000 77 240 · 240 124 · 100 5
DCE axial
(THRIVE)
2.8 9 370 to 400 512 · 192 1.5
Slice gap is one mm and ﬂip angle 90 in all non-contrast sequences.
Abbreviations: FOV= ﬁeld of view; SPAIR = spectral adiabatic
inversion recovery; DWI = diffusion-weighted imaging; DCE=
dynamic contrast enhanced; THRIVE= time high resolution
isotropic volumetric examination.
Table 2 Histopathology, signal intensity at T2WI and DWI and m
Ovarian tumors (n= 235) T2WI
Brigh
Epithelial tumors
–Serous
Borderline cystadenoma (n= 26) 20
Malignant cystadenocarcinoma (n= 29) 2
–Cystadenoﬁbroma
Benign (n= 6) –
Borderline (n= 1) 1
–Mucinous
Borderline cystadenoma (n= 27) 10
Malignant cystadenocarcinoma (n= 21) 2
–Endometrioid carcinoma (n= 6) –
–Clear cell carcinoma (n= 7) –
–Brenner (n= 12)
Benign (n= 11) –
Borderline (n= 1) –
–Undiﬀerentiated carcinoma (n= 5) –
Germ cell tumors
–Teratoma
Mature with solid components (n= 12) –
Struma ovarii (n= 2) 1
Immature (n= 16) –
–Dysgerminoma (n= 5) –
Sex-cord stromal tumors
–Granulosa-stromal cell tumor
Granulosa cell tumor (n= 5) 4
Fibrothecoma/thecoma (n= 38) 12
Malignant Sertoli-Leydig Cell (n= 4) 1
Metastatic (Krukenberg tumor – n= 6) 2
Others
–Collusion tumor (n= 4) 4
–Endometrioma (n= 1) –
–Squamous cell carcinoma on to of immature teratoma (n= 1) 1
–Granulomatous T.B. (n= 1) 1
Note – data are reported as number.
1280 S. Mansour et al.performed in patients with benign ovarian tumor because the
preoperative diagnosis was inaccurate (2).
Preoperative diagnosis of ovarian tumors based on imaging
is important as biopsy is not commonly applicable (3).
Ultrasonography (US) is the ﬁrst-line imaging modality for
adnexal lesions and is a particularly useful preoperative test
for the characterization of noncomplex masses. Magnetic
resonance imaging (MRI) may be of great help in identifying
malignant lesions before surgery, particularly when US
ﬁndings are suboptimal or indeterminate (4).
MR imaging displays morphologic characteristics and
signal intensity variations on T1- and T2-weighted images
for diagnosis of ovarian masses. Features such as papillary
projections, mural nodules, thick septa and solid components
can be easily distinguished on MR images, yet these criteria
cannot reliably distinguish malignant from benign tumors (5).
With recent advances in ultrafast MR imaging techniques,
diffusion weighted (DW) imaging is available to assess discrim-
inant cellular characteristics in abdominal and pelvic organs.
DWI is sensitive to changes in the microdiffusion of water intoeasured mean ADC values of included ovarian masses.
SI DCE-MR DWI
(b= 1000)
Mean ADC
value · 103
t Intermediate Early Delayed Bright SI
6 10/22 12/22 23/26 1.1 ± 0.22
27 26/27 1/27 29 0.9 ± 0.22
6 – 3/6 1/6 1 ± 0.18
– – 1 – 1.9
17 18/26 8/26 27 1.2 ± 0.21
19 21 – 21 0.8 ± 0.18
6 6 – 6 0.8 ± 0.11
7 7 – 7 0.75 ± 0.13
11 – 11 4/11
1 – 1 1 1.1 ± 0.30
5 3/3 – 5 0.7 ± 0.22
12 /10 4/10 5/12 1.2 ± 0.18
1 – 2 1/2 1.4 ± 0.14
16 11 5 16 1.0 ± 0.81
5 3 2 5 0.7 ± 0.14
1 4 1 5 0.9 ± 0.2
26 11 27 12/38 1.3 ± 0.18
3 3 1 4 0.7 ± 0.13
4 5 1 6 1.2 ± 0.11
– – 1/4 3/4 1.5 ± 0.16
1 1 – 1 0.7
– – – 1 0.8
– – – 1 1
Fig. 1 Premenopausal 30-year-old female with bilateral ovarian masses, right endometrioma and left endometrioid carcinoma. (a) Axial
T1- (right image) and T2- (left image) weighted FSE showed bilateral ovarian complex masses with SI of blood products, the left mass
displayed irregular wall and thickened septae. (b) Axial oblique DWI with different b values (0, 500, 1000, 1500) showed high SI in the
right endometrioma that faded with increasing the b value and persistent high SI of the malignant tissue in the left endometrioid
carcinoma; Rt= right, Lt. = left and Asc. = ascites. (c) Axial DWI with different b values (0, 500, 1000, 1500) that demonstrated
adhesions between the left endometrioid carcinoma and the uterus and the peritoneum (arrows); u = uterus. Note the persistent bright SI
of the intracystic clots in the right endometrioma (asterisk – one of the DWI sequence pitfalls).
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Fig. 2 Female patient 20-year-old with right ovarian granulosa cell tumor. (a) Coronal T2-weighted FSE showed large pelvic
predominantly solid mass (asterisk) of intermediate to high SI with some scattered tiny cysts seen within; A= ascites and UB = urinary
bladder. (b) Axial oblique DWI with b values (0, 500, 1000 and 1500), the mass showed typical high SI that coincided with malignant
tumors. (c) ADC map; the measured ADC value was low: 0.7 · 103 mm2/s.
1282 S. Mansour et al.both intracellular and extracellular spaces (6), but its clinical
application requires experience in image interpretation (7).
The purpose of this work was to assess the ability of DWI,
being a non-invasive cost-effective option compared to
postcontrast MR series, to distinguish malignancy in
ovarian masses. Pearls and pitfalls of such sequence that may
affect the efﬁcacy of MRI in assessing these masses were spotted.
2. Patients and methods
2.1. Patients
The current work is a retrospective analysis approved by the
Ethics Committee of the Faculty of Medicine- Cairo
University and cases had been supplied by Kasr Al Ainy
Hospital with waiver on their informed consent.
DWI in addition to the routine pelvic MRI protocol was
done to 204 female patients with 247 ovarian/adnexal masses
from January 2012 till June 2014.
The mean patient age was 39.3 ± 12.5 (range: 17–72) years.
Premenopausal patients comprised 68% (n= 134) and
postmenopausal 32% (n= 63).
Inclusion criteria of suspicion were as follows: (1) complex
cystic or solid ovarian masses and (2) purely solid ovarian
masses with atypical signal intensity (high/intermediate-high
SI on T2WI) and showed early intense enhancement in the
postcontrast series.
We excluded masses with typical benign MR features (5)
whether they were purely cystic or purely solid with low
T2-weighted signal intensity (SI).2.2. Methods
All cases had undergone preliminary transabdominal/
transvaginal pelvic US; using 3.5–5 MHz sector/9 MHz
endoluminal transducers on LOGIQ 7 PRO, GE (General
electric medial system) US machine.
2.2.1. Magnetic resonance imaging
DWI was done in the axial oblique plane to make use of its
capacity in discriminating benign from malignant ovarian
masses. Masses of interest scanned using the b values: zero,
500, 1000 and 1500 s/mm2. DW images with a b-value of 0
and 500 s/mm2 were not evaluated because of the displayed
less diffusion and larger T2 shine-through effect yet they are
needed to provide a postprocessing ADC map with a good res-
olution and consequently develop an accurate measurement of
the ADC value.
MRI was performed for all cases using a 1.5-T magnet
(Gyroscan INTERA and ACHIEVA, Philips medical systems,
the Netherland). Cases were imaged in the supine position
using pelvic phased-array coil with eight channels.
Table 1 shows the MRI protocol performed in the current
study.
Dynamic postcontrast sequence was accessible for the
assessment of 190 cases (225 masses).
Contrast media was not used in three pregnant cases (six
masses: bilateral undifferentiated adenocarcinoma (grade II)
in one case and bilateral borderline serous cystadenoma in
the other two cases (Fig. 3)). This was also encountered in four
other cases with renal failure (one case with malignant serous
Fig. 3 Twenty-eight-year-old pregnant female with bilateral ovarian papillary serous cystadenoma (borderline tumor). (a) Coronal T2-
weighted FSE shows bilateral large ovarian complex masses that showed turbid (intermediate SI) ﬂuid content and mural based numerous
papillary projections (arrows); GU= gravid uterus. (b) Axial oblique DWI at b 0 and 1500 and ADC map of the masses showed bright SI
decay of the papillary projections in the DWI and bright SI in the ADC map (arrow). The measured mean ADC value was
1.1 · 103 mm2/s (not included in the images). Assessment of the case was applicable with no need to contrast media, the ovarian masses
displayed suspicious/malignant features on the conventional MRI yet the signal decay in the DWI, bright SI in ADC map and high mean
ADC value favored the possibility of low potential malignancy more than invasive carcinoma.
Table 3 Statistical analysis of (conventional MRI + DWI)
compared to (conventional MRI + DCEMRI).
Conventional
MRI + DWI
Conventional
MRI + DCE-MRI
Sensitivity 93.3% 93.3%
Speciﬁcity 85% 100%
PPV 88.5% 100%
NPV 94.4% 92.3%
Accuracy 82.3% 95%
LHR +ve 1.1107 0.9424
LHR ve 1.0859 0.923
Diffusion-weigthed imaging and ovarian tumors 1283cystadenocarcinoma, another case with borderline muci-
nous cystadenoma and two cases with mature teratoma
(Fig. 7)).
2.3. Image analysis
MR image interpretation was performed by two qualiﬁed
consultants of radiology (M.S. and W.R. each of 15 years
experience in pelvic MR imaging), and quantitative analysis
was done by M.S. and another certiﬁed radiologist (R.M. of
12 years experience). Authors were blinded about each other
imaging ﬁndings and they were not aware about the pathology,
tumormarkers or pelvicUSdata at the time of initial evaluation.
Masses considered were those with solid components
whether purely solid or complex as those are the candidates
for evaluation on DWI sequence.
In our MRI interpretation:
(i) Following Stevens et al. (8), we considered criteria for
prediction of ovarian malignancy: (1) cystic masses with
thickness (>3 mm) of the walls and septa; and (2) inter-
nal structure, including papillary projections, nodularity,
various degrees of solid components, necrosis, and
hemorrhage.(ii) Our data analysis focused upon T2- and DWI SI and
measured ADC values for the solid tissue of the ovarian
masses.
DW images were taken in the axial oblique orientation and
were inspected for the presence of persistent high SI (restricted
diffusion) in correlation with the solid components of the
included masses. Matched ADC maps were applicable using
a Phillips Advantage windows workstation with functional
tool software. We measured the ADC values by manually
applying ROI on the solid portions of the masses. ROI was
Fig. 4 A 55-year-old patient presented with right ovarian clear cell carcinoma, bowel inﬁltration and peritoneal implants. (4a) Axial T2-
weighted image FSE showed the right ovarian carcinoma (thick black arrow) and the left iliac region showed suspected inﬁltrations in the
transverse colon (ﬁne blue arrow); C = caecum and TC = transverse colon. (4b) Axial oblique DWI showed persistent high SI in all of the
used b values (0, 500, 1000 and 1500) of the solid component of the right ovarian carcinoma (blue arrow, b 500), the left iliac omental cake
(curved arrows) and the right subdiaphragmatic and peritoneal/serosal implants (glowed blue arrows, at b 1000) which are easily
distinguished.
1284 S. Mansour et al.speciﬁcally placed at areas of bright SI on DW images. For
masses with obvious solid component, a large ROI was applied
to cover as much as possible of the pathology, in case of
masses with vegetations or thickened septae; multiple ROIs
were applied to the areas of concern.
Cutoff ADC value of malignancy was 1.2 · 103 mm2/s
(4,9–10)
The mean ADC value was the value used in our data
analysis.
The possible pathology of the ovarian tumors was
suggested by MR imaging and DWI whether benign or malig-
nant had been correlated with surgical pathology specimen.
Nine masses detected in four cases seemed to be of ovarian
etiology but on correlation with the pathology found to be of
peritoneal origin and excluded. Another three masses
mimicked ovarian malignancy and also excluded as they were
subserous pedunculated leiomyomas of the uterus.
We used software (SPSS for Windows, version 10.0.1, 1999;
SPSS, Chicago, Ill) for statistical analysis.3. Results
Two hundred and thirty ﬁve complex or purely solid ovarian
masses were examined in 197 patients. Masses included 75(32%) benign and 160 (68%) malignant pathologies.
Malignant masses comprised 55 (23.4%) borderline of low
potential malignancy and 105 (44.6%) invasive malignant.
Table 2 demonstrated the types of included masses regard-
ing histopathology, signal intensity at T2WI and DWI and
measured mean ADC values.
Masses of intermediate SI on T2WI comprised 74%
(n= 174/235), seen more frequently in invasive carcinomas
(54%, n= 94/174) (Figs. 1 and 2), than benign (32.2%,
n= 56/174) andborderline (13.8%, n= 24/174) (Fig. 3)masses.
Bright SI was displayed on T2WI by 26% (n= 61/235) of the
included masses, about 29.5% of them were benign
(n= 18/61) (Figs. 6 and 7), 50.8% (n= 31/61)
borderline (Fig. 5) and 19.7% (n= 12/61) malignant masses
(P< 0.01).
In the current work, we considered DWI with b value: 1000,
such value provided accepted image resolution with minimal
artifacts. High SI was observed in 78.3% (n= 184/235) of
the considered masses; this included all of the invasive ovarian
masses (57.1%, n= 105/184) (Figs. 1 and 2). Benign (Figs. 6
and 7) and borderline (Fig. 3) ovarian tumors with restricted
diffusion presented 15.2% (n= 28/184) and 27.7%
(n= 51/184) respectively (P < 0.05).
Facilitated diffusion (bright signal decay) was detected in
three masses of borderline serous cystadenoma, ﬁve masses
Fig. 5 Forty-year-old female with right atypical proliferative papillary serous cystadenoﬁbroma (borderline tumor). (a) Axial
T2-weighted FSE showed right complex cystic ovarian mass with intracystic cauliﬂower pedunculated solid component (thin arrow). Note
the right ovary simple cyst (star), adenomyosis justiﬁed by thick junctional zone of the uterus with bright endometrial nests (arrows heads)
and left hydrosalpinx (thick arrow). (b) Axial oblique DWI and ADC map, the solid component (arrow) showed features of low cellularity
of high SI on both the DW images and ADC map and a high ADC value of 1.9 · 10–3 mm2/s.
Diffusion-weigthed imaging and ovarian tumors 1285of cystadenoﬁbroma, seven masses of brenner tumor, seven
masses of mature solid teratoma, one struma ovarii, 26 ﬁbroth-
ecomas and four collusion tumors.
The mean ADC for benign ovarian masses was
1.2 + 0.34 · 103 mm2/s, for borderline masses was
1.1 + 0.06 · 103 mm2/s, and for malignant tumors 0.83 +
0.15 · 103 mm2/s.
The ADC values of malignant ovarian masses and some
benign masses with ﬁbrous solid components (i.e. cystadenoﬁ-
bromas, Brenner tumors and ﬁbrothecomas) showed nosigniﬁcant difference (P> 0.05–0.333). Signiﬁcant difference
was detected between values for mature teratomas and colli-
sion tumors and malignant masses (P= 0.002).
MRI analysis with the aid of diffusion sequence and ADC
values showed discordant outcomes with the complete pathol-
ogy specimen in 12 false positive (four Brenner tumor, ﬁve
mature teratoma masses, one endometrioma, one cystadenoﬁ-
broma and one granulomatous tuberculosis) and 15 false neg-
ative (three borderline serous cystadenomas, ﬁve borderline
mucinous cystadenomas, two Krukenberg tumors, one
Fig. 6 Thirty-year-old female with right ovarian granulomatous tuberculosis (T.B.). (a) Sagittal T2WI FSE (right image) and coronal T1
postcontrast (left image), showed large right complex cystic ovarian/adnexal mass (thin arrows) with thick walled multiple loculations and
turbid content. The mass showed no appreciable contrast uptake (curved arrows); Asc.= Ascites, UB = urinary bladder. Note bulky left
ovary and indistinct outline (thick arrow). (b) Coronal TWI FSE, pathologically enlarged right para-aortic and iliac lymph nodes (arrows
in the right image), and thickened right iliopsoas muscle and abnormal SI of its bulk (arrows in left image). (c) and (d) Axial oblique DWI
and ADC map, the mass showed areas of restricted diffusion and suspicious ADC value of 0.9 · 103 mm2/s, there are right iliac nodes
with normal morphology yet displayed abnormal bright SI on (c). Persistent bright SI of the thickened right iliopsoas muscle (curved lines)
and the elicited ADC value is 0.8 · 103 mm2/s in spite of being a granulomatous abscess in (d). A similar yet minor condition involved the
right external oblique muscle as well (straight arrow).
1286 S. Mansour et al.endometrioid carcinoma, two clear cell carcinomas and two
undifferentiated adenocarcinomas) diagnoses.
The sensitivity, speciﬁcity, positive predictive value (PPV),
negative predictive value (NPV) and accuracy of the DW
sequence (with the pre-contrast MR sequences) in the assess-
ment of ovarian masses yielded 93.3%, 85%, 88.5%, 94.4%
and 82.3% respectively.
We performed a comparative evaluation for the diagnostic
performance of the routine MRI pelvis examination in addi-
tion to each of DWI and DCE-MRI in the assessment of
225 (Contrast media was not applicable in 7 cases = 10
masses) shown in Table 3.
The signiﬁcance of adding DWI to the non-contrast MR
examination of the pelvis was comparable to the expensive
postcontrast series in its sensitivity and also showed a near
speciﬁcity and accuracy value. DWI performance showed
positive likelihood ratio (LHR) = 1.1 that emphasis that there
is almost no change in the likelihood of disease and a negative
LHR= 0.8 which indicates decreased probability of target
disorder presence.4. Discussion
Among the advantages of DWI is that it is a noninvasive tech-
nique and it does not require injection of contrast material,
thus enabling its use in patients with renal dysfunction (11).
In 2004 there was an initial experience that tried to
determine the feasibility of using ADC measurement for the
differential diagnosis of malignancy in only 12 cases. Theresearch was descriptive rather than analytic and the main
challenge at that time was image motion artifact. Finally the
study group concluded ADC measurement, intensity and tex-
ture have the capability to distinguish malignancy in ovarian
masses (12).
Since then, several studies had analyzed the added value of
DWI to conventional MRI protocol in order to differentiate
benign from malignant adnexal/ovarian tumors (2,4,9,10,6,13).
A recent study done on 2013 found out that high SI on
DWI is frequently seen in malignant lesions rather than benign
ones (P= 0.001) and that there was no signiﬁcant difference in
the ADC value (P= 0.22) (13). But this study could not be
used as a solid reference, because of the limited number of
the studied cases (23 patients).
Focusing on the quantitative and not the qualitative
analysis of DWI was the purpose of a Turkish study which
evaluated 59 ovarian masses. The study group declared that
the ADC values of benign and malignant ovarian lesions over-
lap and DWI cannot be used for discrimination (10). The
drawback in their analysis is the unawareness about DWI pit-
falls. They included purely cystic lesions such as endometri-
omas, hemorrhagic cysts and dermoid cysts, which in spite
of being cystic yet they present with low ADC values and so
can overlap with those of malignant masses. Also the studied
sample size was limited.
On the other side Thomassin-Naggara and her co-workers
performed a prospective analysis to check the possibility of
DWI to characterize 77 adnexal masses. According to them,
on the contrary to almost all of the comparable researches,
they considered the SI at the DWI to be the accurate tool
Fig. 7 Right ovarian mature teratoma in 45-year-old female. (a) Axial T2WI FSE (right image) and fat suppressed sequence (left image),
showed complex cystic mass in the conﬁne of the right ovary (thin arrows) with thick sepatations and solid component. The mass showed
suppressed signal in the fat suppression sequence characteristic of teratoma (whether mature/immature). (b) Axial oblique DWI and (c)
ADC map; the mass showed areas of restricted diffusion elicited by the solid component and low ADC value of 0.7 · 103 mm2/s. Here
the mixed cellularity of the teratoma hindered DWI to differentiate between mature (benign) and immature (malignant) versions of
teratomas.
Diffusion-weigthed imaging and ovarian tumors 1287for predicting benign/malignant criteria not the ADC values
(6).
All of the aforementioned studies recorded the SI of DWI
at b 1000 and the ADC measurements of both cystic and solid
components of the examined masses.
A research work performed on 2011 studied only solid or
predominantly solid gynecological adnexal masses. Although
they evaluated the signal intensity of DWI at a rather low b
value (i.e. 800 s mm2), yet they suggested that high SI seenon DWI was more frequently observed with the malignant
lesions (14).
In the current work we evaluated the SI of DWI at b 1000
and measured ADC value of the solid component of the ovar-
ian masses.
The diagnostic performance of the DW sequence was
statistically analyzed after considering the conventional MR
ﬁndings in addition to the DW sequence data. The reason
for this is that, during our work we found out that the
1288 S. Mansour et al.individual performance of DWI could lead to serious misinter-
pretations and improper case management. For example false
positive ﬁndings could be elicited from noncellular, highly con-
centrated molecular components as debris and caseous mate-
rial (Fig. 6). A comparable situation could also be found
with keratinoid substances and Rokitansky protuberance in
mature cystic teratomas (Fig. 7) and compact cellular organi-
zation due to products of hemoglobin degradation in benign
endometrioma (right ovarian mass in Fig. 1), since all of these
masses display features of restricted diffusion (3). But to be
fair, regarding the individual performance of the diffusion-
weighted sequence, although endometriomas could present
false positive diagnosis yet the associated pelvic adhesions
(knowledge of this ﬁnding is very important for the manage-
ment) could be easily elicited in such sequence unlike the other
MRI sequences (Fig. 1c).
There were even times where the conventional imaging
presented a false impression of benign/malignancy and data
provided by the DWI were the ones matching with the pathol-
ogy (Figs. 3 and 5).
Diffusion weighted imaging was not just providing data for
differentiation, moreover focal area of restricted diffusion seen
in an occluded bowel with thickened walls favors bowel inﬁltra-
tion and sugessted advanced disease stage (Fig. 4a and b).
Add to this the enhanced detection of the metastatic peritoneal
carcinomatosis (Fig. 4b) in areas which were difﬁcult to assess
due to the background signal suppression provided by the
diffusion-weighted images.
Although some overlaps were found in the ADC values of
benign and malignant lesions, yet the mean ADC value of
malignant ovarian masses was signiﬁcantly lower than that
of benign and borderline ones (P < 0.05). Combined qualita-
tive (DWI/ADC SI) and quantitative (ADC values) analyses
with cutoff value of 1.2 · 103 mm2/s provided a good perfor-
mance in the diagnosis and categorization (benign, borderline
and invasive malignant) of the suspicious ovarian masses on
MRI (Figs. 1–5).
In a comparable retrospective study (15), the authors evalu-
ated the performance of the DWI in the characterization of 123
ovarian lesions using both qualitative and quantitative ADC
analyses. They concluded that there were many overlaps
between the ADC values of the malignant and benign ovarian
masses. This result may be attributed to the condition of includ-
ing cystic masses (18 mature cystic teratomas and 24 endometri-
omas) with discrepant pathologic architecture and masses with
abundant ﬁbrous stroma (7 ﬁbromas) in their evaluation.
So during analysis we have to put in mind that benign
masses such as ﬁbrothecomas, cystadenoﬁbromas and
Brenner tumors, display low SI in T2WI and DWI may be
due to the high density of ﬁbers, the low cellularity, and the
low water content in both extracellular and intracellular spaces
(16,17). We had in our study seven cystadenoﬁbromas, 12
Brenner tumors and 38 ﬁbrothecomas, and they presented
either with atypical SI on T2WI (intermediate/intermediate–h
igh) or a rather complex pattern. The ADC values of these
pathologies showed no signiﬁcant difference (P= 0.333) with
respect to malignant masses.
The strength of the current study lies in: (1) The inclusion to
a large number of ovarian masses (235) of different varieties,
(2) the retrospective analysis which provided the opportunity
to standardize the study conditions, and consequently made
the use of the advantages of DWI as well as took care of thesequence pitfalls in assessment. We had to mention that the
inclusion of only masses with purely solid or complex compo-
nents may have resulted in selection bias.
Moreover, DWI can be used as an alternative to contrast
sequences for patients with renal failure and in case of preg-
nancy (Fig. 3). In the current work seven patients have beneﬁt
from such advantage. Conventional MRI combined with DWI
was able to provide accurate diagnose in all of them.
5. Conclusion
The solo performance of DWI is not an applicable way to dis-
criminate benign from malignant ovarian masses. DWI can
conﬁrm or exclude potential malignancy in suspicious ovarian
masses; provided (i) inclusion of the conventional MRI data,
(ii) combined analysis of DWI quantitative and qualitative
criteria and (iii) awareness of the sequence pitfalls.
Conﬂict of interest
We have no conﬂict of interest to declare.
References
(1) Pierce N, Narayanan P, Sahdev A, Reznek R, Rockall A. Ovarian
lesions pose diagnostic dilemmas. Diagnostic Imaging Eur
2008;24(3):14–8.
(2) Kim KA, Park CM, Lee HJ, et al. Benign ovarian tumors with
solid and cystic components that mimic malignancy. AJR Am J
Roentgenol 2004;182:1259–65.
(3) Takeuchi M, Matsuzaki K, Nishitani H. Diffusion-weighted
magnetic resonance imaging of ovarian tumors: differentiation of
benign and malignant solid components of ovarian masses. J
Comput Assist Tomogr 2010;34(2):173–6.
(4) Zhang P, Cui Y, Li W, Ren G, Chu C, Wu X. Diagnostic
accuracy of diffusion-weighted imaging with conventional MR
imaging for differentiating complex solid and cystic ovarian
tumors at 1.5 T. World J Surg Oncol 2012;10:237.
(5) Imaoka I, Wada A, Kaji Y, Hayashi T, Hayashi M, Michimasa
M, et al. Developing an MR imaging strategy for diagnosis of
ovarian masses1. Radiographics 2006;26(5):1431–48.
(6) Thomassin-Naggara I, Toussaint I, Perrot N, Rouzier R, Cuenod
CA, Bazot M, et al. Characterization of complex adnexal masses:
value of adding perfusion- and diffusion-weighted MR imaging to
conventional MR imaging. Radiology 2011;258(3):793–803.
(7) Kyriazi S, Collins DJ, Morgan VA, Giles SL, deSouza NM.
Diffusion-weighted imaging of peritoneal disease for noninvasive
staging of advanced ovarian cancer. Radiographics
2010;30:1269–85.
(8) Stevens SK, Hricak H, Stern JL. Ovarian lesions: detection and
characterization with gadolinium-enhanced MR imaging at 1.5 T.
Radiology 1991;181:481–8.
(9) Yousef RH, Algebally AM, Tantawy HI. Can diffusion weighted
imaging distinguish between benign and malignant solid or
predominantly solid gynecological adnexal masses? Egypt J
Radiol Nucl Med 2013;44(1):113–9.
(10) Inci E, Kilic¸kesmez O¨, Gu¨rses B, Tasdelen N, Aydin S, Cimilli T,
et al. Quantitative diffusion-weighted magnetic resonance imag-
ing of ovarian masses. Turkiye Klinikleri 86. J Med Sci
2011;31(1):86–92.
(11) Motoshima M, Irie H, Nakazono T, Kamura T, Kudo S.
Diffusion-weighted MR imaging in gynecologic cancers. J
Gynecol Oncol 2011;22(4):275–87.
(12) Sarty GE, Kendall EJ, Loewy J, Dhir A, Olatunbosun OA,
Pierson RA. Magnetic resonance diffusion imaging of ovarian
Diffusion-weigthed imaging and ovarian tumors 1289masses: a ﬁrst experience with 12 cases. MAGMA
2004;16:182–93.
(13) El sorogy L, Abd El gaber N, Omran E, Elshamy M, Youssef H.
Role of diffusion MRI and proton magnetic resonance spec-
troscopy in characterization of ovarian neoplasms. Egypt J
Radiol Nucl Med 2012;43(1):99–106.
(14) Bakir B, Bakan S, Tunaci M, Bakir VL, Iyibozkurt AC, Berkman
S, et al. Diffusion-weighted imaging of solid or predominantly
solid gynaecological adnexial masses: is it useful in the differential
diagnosis? Br J Radiol 2011;84(1003):600–11.
(15) Fujii S, Kakite S, Nishihara K, Kanasaki Y, Harada T, Kigawa J,
et al. Diagnostic accuracy of diffusion-weighted imaging indifferentiating benign from malignant ovarian lesions. J Magn
Reson Imaging 2008;28(5):1149–56.
(16) Moteki T, Ishizaka H. Evaluation of cystic ovarian lesions using
apparent diffusion coefﬁcient from turboFLASH MR images. Br
J Radiol 1998;71:612–20.
(17) Nakai G, Matsuki M, Inada Y, Tatsugami F, Tanikake M,
Narabayashi I, et al. Detection and evaluation of pelvic lymph
nodes in patients with gynecologic malignancies using body
diffusion-weighted magnetic resonance imaging. J Comput Assist
Tomogr 2008;32:764–8.
